1 / 7

Radiofrequency Ablation Devices Market Size, Share | Industry Report, 2020 | Hexa Research

Rising prevalence of target disorders such as osteoporosis pain, benign prostatic obstruction (BPO) is a high impact rendering driver for the growth of radiofrequency ablation devices market.

Carrol
Download Presentation

Radiofrequency Ablation Devices Market Size, Share | Industry Report, 2020 | Hexa Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Your Catalyst To a Lucrative Business Radiofrequency Ablation Devices Market Analysis, Size, Share, Growth and Forecast to 2020 - Hexa Research "Rising prevalence of target disorders such as osteoporosis pain, benign prostatic obstruction (BPO) is a high impact rendering driver for the growth of Radiofrequency Ablation Devices Market." The global Radiofrequency Ablation Devices Market is anticipated to expand at a nearly 18.5% CAGR over the forecast period (2012 to 2020). The industry may reach around USD 9 billion by 2020. High incidence of target pain related disorders, such as osteoporosis and benign prostatic obstruction (BPO) drives market demand. Furthermore, a rapidly expanding geriatric population could further contribute to overall demand. This is because the elderly are more susceptible to developing cardiovascular ailments and chronic pains, such as arthritis. Product innovations aim at fostering user friendliness and cost efficiency. Other factors that fuel the global market are popularity of minimally invasive surgeries, low infection risks, and greater preference for shorter hospital stays. The worldwide Radiofrequency Ablation Devices Market is classified as per products, applications, and regions. Based on products, the industry is segmented into reusable equipment, disposable equipment, and capital equipment. Reusable equipment comprise electrodes and probes. Disposable equipment is further categorized into single-use electrodes, single-use probes, needles, and cannulae. In revenue terms, disposable equipment held the highest industry share in 2013. It may expand at a CAGR more than 20% over the forecast period. The market for disposable equipment is primarily fueled by demand for minimally invasive surgical procedures and government initiatives that aim at controlling hospital acquired diseases. High demand for reusable radiofrequency ablation devices owes to the cost effectiveness of endoscopic & laparoscopic interventions. Browse Details of Report @ https://www.hexaresearch.com/research-report/radiofrequency-ablation- devices-industry Follow Us:

  2. Your Catalyst To a Lucrative Business On the basis of applications, the market is divided into surgical oncology, cosmetology, hypertension, pain management, cardiac rhythm management, gynecology, and cardiology. The overall industry was led by the surgical oncology segment in 2013. Factors that propel this market segment are high procedure volumes and high incidence of different types of cancers. Demand for radiofrequency ablation devices for hypertension could expand at a whopping CAGR over 26% till 2020. This attributes to huge R&D investments and demand from patients since these devices usually do not lead to post operative complications. Geographically, the worldwide Radiofrequency Ablation Devices Market is segmented into Asia Pacific, North America, Europe, and Rest of the World. In 2013, North America dominated the overall industry because of high healthcare expenditure and sophisticated medical infrastructure. Other regional drivers are rising cases of pain related ailments, growing aging population, and unhealthful lifestyles. In 2013, Europe held the second highest industry share after North America. The Asia Pacific market is poised to grow at a remarkable CAGR over 20% during the forecast period. Favorable government initiatives and economic progress fuel regional demand. Improvements in healthcare infrastructure in emerging economies, such as China and India could further market progress in the forthcoming years. Extensive use of radiofrequency ablation procedures in countries, such as China, Brazil, India, and Russia could create lucrative growth opportunities in the overall industry. Widespread awareness among patients and high disposable incomes are prominent factors that drive these regions. Key industry participants in the Radiofrequency Ablation Devices Market are Biosense Webster, Kimberly- Clark Corporation, Boston Scientific, Covidien, Diros Technology, and Stryker Corporation. In August 2016, Boston Scientific acquired U.S. based manufacturer of RF (radiofrequency) generators and cannulae, Cosman Medical. The main rationale of such a business venture is to develop solutions for chronic pain via non opioid therapeutic treatments. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices- industry Follow Us:

  3. Your Catalyst To a Lucrative Business Table of Content of Radiofrequency Ablation Devices Market Chapter 1. Executive Summary Chapter 2. Radiofrequency Ablation Devices Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Radiofrequency Ablation Devices - Market dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Radiofrequency Ablation Devices - PESTEL Analysis 2.6. Radiofrequency Ablation Devices Company Market Share Analysis, 2013 Chapter 3. Radiofrequency Ablation Devices Application Outlook 3.1. Surgical Oncology Volume and Revenue Estimates, 2012 - 2020 3.2. Cardiology & Cardiac Rhythm Management Volume and Revenue Estimates, 2012 - 2020 3.3. Pain Management Volume and Revenue Estimates, 2012 - 2020 3.4. Gynecology Volume and Revenue Estimates, 2012 - 2020 3.5. Hypertension Volume and Revenue Estimates, 2012 - 2020 3.6. Cosmetology Volume and Revenue Estimates, 2012 - 2020 Chapter 4. Radiofrequency Ablation Devices Product Outlook 4.1. Radiofrequency ablation devices market share, by product, 2013 & 2020 4.2. Capital Equipment 4.2.1. Market Estimates, By Application, 2012 - 2020, Revenue & Volume 4.3. Reusable Equipment 4.3.1. Market Estimates, By Application, 2012 - 2020, Revenue & Volume 4.3.1.1. Reusable Radiofrequency Probes 4.3.1.2. Reusable Radiofrequency Electrodes 4.4. Disposable Equipment 4.4.1. Market Estimates, By Application, 2012 - 2020, Revenue & Volume 4.4.1.1. Disposable Radiofrequency Cannulas 4.4.1.2. Disposable Radiofrequency Needles Follow Us:

  4. Your Catalyst To a Lucrative Business 4.4.1.3. Disposable Radiofrequency Single-Use probes 4.4.1.4. Disposable Radiofrequency Single-Use Electrodes Chapter 5. Radiofrequency Ablation Devices Regional Outlook 5.1. Radiofrequency ablation devices revenue share by region, 2012 & 2020 5.2. North America 5.2.1. Market Estimates and Forecasts, by Application 5.2.2. Market Estimates and Forecasts, by Product 5.3. Europe 5.3.1. Market Estimates and Forecasts, by Application 5.3.2. Market Estimates and Forecasts, by Product 5.4. Asia Pacific 5.4.1. Market Estimates and Forecasts, by Application 5.4.2. Market Estimates and Forecasts, by Product 5.5. RoW 5.5.1. Market Estimates and Forecasts, by Application 5.5.2. Market Estimates and Forecasts, by Product Chapter 6 Competitive Landscape 6.1 Accuray 6.1.1 Company Overview 6.1.2 Financial Performance 6.1.3 Product Benchmarking 6.1.4 Strategic Initiatives 6.2 Biosense Webster 6.2.1 Company Overview 6.2.2 Financial Performance 6.2.3 Product Benchmarking 6.2.4 Strategic Initiatives 6.3 Cosman Medical Inc. 6.3.1 Company Overview 6.3.2 Financial Performance 6.3.3 Product Benchmarking 6.3.4 Strategic Initiatives 6.4 Diros Technology Inc. 6.4.1 Company Overview Follow Us:

  5. Your Catalyst To a Lucrative Business 6.4.2 Financial Performance 6.4.3 Product Benchmarking 6.5 NeuroTherm (St. Jude Medical). 6.5.1 Company Overview 6.5.2 Financial Performance 6.5.3 Product Benchmarking 6.5.4 Strategic Initiatives 6.6 St. Jude Medical. 6.6.1 Company Overview 6.6.2 Financial Performance 6.6.3 Product Benchmarking 6.6.4 Strategic Initiatives 6.7 Stryker Corporation. 6.7.1 Company Overview 6.7.2 Financial Performance 6.7.3 Product Benchmarking 6.7.4 Strategic Initiatives 6.8 Kimberly-Clark. 6.8.1 Company Overview 6.8.2 Financial Performance 6.8.3 Product Benchmarking 6.8.4 Strategic Initiatives 6.9 RF Medical Co. Ltd. 6.9.1 Company Overview 6.9.2 Financial Performance 6.9.3 Product Benchmarking 6.9.4 Strategic Initiatives 6.10 AngioDynamics. 6.10.1 Company Overview 6.10.2 Financial Performance 6.10.3 Product Benchmarking 6.10.4 Strategic Initiatives 6.11 Covidien. 6.11.1 Company Overview 6.11.2 Financial Performance 6.11.3 Product Benchmarking Follow Us:

  6. Your Catalyst To a Lucrative Business 6.11.4 Strategic Initiatives 6.12 DFINE Inc. 6.12.1 Company Overview 6.12.2 Financial Performance 6.12.3 Product Benchmarking 6.12.4 Strategic Initiatives 6.13 STARmed. 6.13.1 Company Overview 6.13.2 Financial Performance 6.13.3 Product Benchmarking 6.13.4 Strategic Initiatives 6.14 Boston Scientific. 6.14.1 Company Overview 6.14.2 Financial Performance 6.14.3 Product Benchmarking 6.14.4 Strategic Initiatives Chapter 7. Methodology and Scope 7.1. Research Methodology 7.2. Research Scope & Assumption 7.3. List of Data Sources Follow Us:

  7. Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit Our Blog - https://hexaresearchinc.wordpress.com/ Follow Us:

More Related